These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38991294)

  • 1. Construction and synergistic anti-tumor study of a tumor microenvironment-based multifunctional nano-drug delivery system.
    Liu B; Zheng Q; Shi X; Shen J; Li R; Zhou J
    J Photochem Photobiol B; 2024 Sep; 258():112977. PubMed ID: 38991294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemo-photodynamic combined gene therapy and dual-modal cancer imaging achieved by pH-responsive alginate/chitosan multilayer-modified magnetic mesoporous silica nanocomposites.
    Yang H; Chen Y; Chen Z; Geng Y; Xie X; Shen X; Li T; Li S; Wu C; Liu Y
    Biomater Sci; 2017 May; 5(5):1001-1013. PubMed ID: 28327716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic antibacterial research on hypericin-loaded PEGylated mesoporous silica delivery system.
    Huang X; Zhan Y; Xiao Z; He S; Hu L; Zhu H; Guo H; Sun H; Liu M
    J Biomater Sci Polym Ed; 2024 Aug; 35(12):1795-1818. PubMed ID: 38801735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-LDLR modified TPZ@Ce6-PEG complexes for tumor hypoxia-targeting chemo-/radio-/photodynamic/photothermal therapy.
    Song C; Xu W; Wei Z; Ou C; Wu J; Tong J; Cai Y; Dong X; Han W
    J Mater Chem B; 2020 Jan; 8(4):648-654. PubMed ID: 31898718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.
    Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupický D
    ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective Photodynamic Effects on Breast Cancer Cells Provided by p123 Pluronic®- Based Nanoparticles Modulating Hypericin Delivery.
    Damke GMZF; Souza RP; Montanha MC; Damke E; Gonçalves RS; César GB; Kimura E; Caetano W; Hioka N; Consolaro MEL
    Anticancer Agents Med Chem; 2020; 20(11):1352-1367. PubMed ID: 30387402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near-infrared photoactivatable three-in-one nanoagents to aggravate hypoxia and enable amplified photo-chemotherapy.
    Yu N; Zhou J; Xu H; Wang F; Wang X; Tang L; Li J; Wang X; Lu X
    Biomater Adv; 2024 Oct; 163():213962. PubMed ID: 39032435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-Selective Bioreductive Chemotherapy Mediated by Dual Hypoxia-Responsive Nanomedicine upon Photodynamic Therapy-Induced Hypoxia Aggravation.
    Zhu R; He H; Liu Y; Cao D; Yan J; Duan S; Chen Y; Yin L
    Biomacromolecules; 2019 Jul; 20(7):2649-2656. PubMed ID: 31125209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing Hypoxia-Sensitive System via Designing Tumor-Targeted Fullerene-Based Photosensitizer for Multimodal Therapy of Deep Tumor.
    Li L; Fu J; Ye J; Liu L; Sun Z; Wang H; Tan S; Zhen M; Wang C; Bai C
    Adv Mater; 2024 Jun; 36(23):e2310875. PubMed ID: 38450765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive enhanced photodynamic therapy and enhanced chemotherapy fighting against malignant tumors with sequential drug release.
    Yang Y; Zhang X; Bai Z; Cui Z; Liang W; Zhang J; Li K; Shi M; Liu Z; Wang J; Li J
    Biomed Mater; 2024 May; 19(4):. PubMed ID: 38697132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodinated cyanine dye-based nanosystem for synergistic phototherapy and hypoxia-activated bioreductive therapy.
    Dong Y; Zhou L; Shen Z; Ma Q; Zhao Y; Sun Y; Cao J
    Drug Deliv; 2022 Dec; 29(1):238-253. PubMed ID: 35001784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An efficient delivery of photosensitizers and hypoxic prodrugs for a tumor combination therapy by membrane camouflage nanoparticles.
    Wang H; Zhang C; Zhang Y; Tian R; Cheng G; Pan H; Cui M; Chang J
    J Mater Chem B; 2020 Apr; 8(14):2876-2886. PubMed ID: 32191252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel semiconducting nano-agents incorporating tirapazamine for imaging guided synergistic cancer hypoxia activated photo-chemotherapy.
    Zhang G; Wang W; Zou H; Wei Z; Song C; Ran J; Cao Z; Cai Y; Han W
    J Mater Chem B; 2021 Jul; 9(26):5318-5328. PubMed ID: 34231629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized Combination of Photodynamic Therapy and Chemotherapy Using Gelatin Nanoparticles Containing Tirapazamine and Pheophorbide a.
    Lee D; Jang SY; Kwon S; Lee Y; Park E; Koo H
    ACS Appl Mater Interfaces; 2021 Mar; 13(9):10812-10821. PubMed ID: 33624503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A photothermal-hypoxia sequentially activatable phase-change nanoagent for mitochondria-targeting tumor synergistic therapy.
    Qu J; Teng D; Sui G; Guan S; Wang Y; Wang Q; Lin Y; Ran H; Wang Z; Wang H
    Biomater Sci; 2020 Jun; 8(11):3116-3129. PubMed ID: 32352102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy.
    Liu H; Jiang W; Wang Q; Hang L; Wang Y; Wang Y
    Biomater Sci; 2019 Aug; 7(9):3706-3716. PubMed ID: 31187794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Near-infrared light triggered liposomes combining photodynamic and chemotherapy for synergistic breast tumor therapy.
    Yang Y; Yang X; Li H; Li C; Ding H; Zhang M; Guo Y; Sun M
    Colloids Surf B Biointerfaces; 2019 Jan; 173():564-570. PubMed ID: 30347383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of mesoporous silica nanoparticle-encapsulated alginate microparticles for sustained release and targeting therapy.
    Liao YT; Wu KC; Yu J
    J Biomed Mater Res B Appl Biomater; 2014 Feb; 102(2):293-302. PubMed ID: 23997043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of multifunctional mesoporous silicon nano-drug delivery system and study of dual sensitization of chemo-photodynamic therapy in vitro and in vivo.
    Xu J; Zhang J; Song J; Liu Y; Li J; Wang X; Tang R
    J Colloid Interface Sci; 2022 Dec; 628(Pt B):271-285. PubMed ID: 35998453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting triple-negative breast cancer with an aptamer-functionalized nanoformulation: a synergistic treatment that combines photodynamic and bioreductive therapies.
    Chou YT; Lin CY; Wen JW; Hung LC; Chang YF; Yang CM; Wu LC; Ho JA
    J Nanobiotechnology; 2021 Mar; 19(1):89. PubMed ID: 33781277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.